Write your message
Volume 18, Issue 2 (May 2024)                   IJT 2024, 18(2): 78-83 | Back to browse issues page

Ethics code: IR.QUMS.REC.1399.546


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Asoudeh-Fard A, Najafipour R, Hosseini A H, Razi F, Salahshourifar I, Zareian Jahromi M, et al . Novel Effects of Phycocyanin Extract on the Regulation of Apoptosis Genes in Human Colorectal Cancer Cells. IJT 2024; 18 (2) :78-83
URL: http://ijt.arakmu.ac.ir/article-1-1294-en.html
1- Laboratory for Vascular Translation Science, Cardiovascular Bioengineering, University Sorbonne, Paris North, Paris, France, and the Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
2- Genetics Research Center, University of Social Welfare and Rehabilitation Science, Tehran, Iran
3- Student Research Committee, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
4- Faculty of Convergent Sciences and Technologies, Islamic Azad University of Science and Research, Tehran, Iran
5- Assistant Professor, Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
6- Assistant Professor, Department of Biology, Jahrom Branch, Islamic Azad University, Jahrom, Iran.
7- Rayan Novin Pajoohan Pars, Biotechnology Company Rep. and Shiraz University of Medical Sciences, Shiraz, Iran
8- Associate Professor, Department of Biochemistry and Genetics, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran , hosseinpiry@gmail.com
Abstract:   (891 Views)
Background: Cancer is a major cause of death worldwide, second only to cardiovascular disease. Many factors influence the development of cancer, including environmental, genetic, and lifestyle factors. Although the prognosis of colon cancer treatment has improved significantly in recent years, there is still much clinical need to explore new treatment strategies with anticancer and immune-enhancing effects. Phycocyanin (PC) is an important compound isolated from blue-green algae and a well-known antioxidant that suppresses oxidative reactions in cells. It also has other useful functions, such as high efficiency, low toxicity, and antitumor properties. We investigated the potential antiapoptotic effect of PC in vitro on human normal and cancer cell lines.
Methods: Phycocyanin extracted from Streptomyces platensis algae has the potential to become a turning point in pharmaceutical research. In this study, PC was used as a natural anticancer agent and apoptosis activator to increase the expression of the PTEN and Bax genes in HT-29 cancer and normal cells (HUVEC). The effect of treatment with PC was evaluated using an MTT assay and flow cytometry.
Results: The results showed that PC can have apoptotic effects on the human colon cancer cell line (HT-29) by up-regulating PTEN and Bax genes and down-regulating AKT and BCL-2 genes.
Conclusion: Based on the findings, PC can be considered a herbal treatment and a useful supplement in the management of human colorectal cancer.
Full-Text [PDF 440 kb]   (200 Downloads) |   |   Full-Text (HTML)  (262 Views)  
Type of Study: Research | Subject: Special

References
1. Curado M-P, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Volume IX: IARC Press, International Agency for Research on Cancer. 2007. [Link]
2. Alexiusdottir KK, Möller PH, Snaebjornsson P, Jonasson L, Olafsdottir EJ, Björnsson ES, et al. Association of symptoms of colon cancer patients with tumor location and TNM tumor stage. Scandinavian Journal of Gastroenterology. 2012;47(7):795-801. [doi:10.3109/00365521.2012.672589]
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA: A Cancer Journal for Clinicians. 2011;61(2):69-90. [doi:10.3322/caac.20107]
4. Hamdan NT, Jwad BA, Jasim SA. Synergistic anticancer effects of phycocyanin and Citrullus colocynthis extract against WiDr, HCT-15 and HCT-116 colon cancer cell lines. Gene Reports. 2021;22:100972. [doi:10.1016/j.genrep.2020.100972]
5. Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1-42. [doi:10.1007/s10147-019-01485-z]
6. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med. 1988;319(9):533-7. [doi:10.1056/NEJM198809013190902]
7. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. JNCI: Journal of the National Cancer Institute. 1981;66(6):1192-308. [doi:10.1093/jnci/66.6.1192]
8. Giovannucci E, Willett WC. Dietary factors and risk of colon cancer. Annals of Medicine. 1994;26(6):443-52. [doi:10.3109/07853899409148367]
9. Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713-32. [doi:10.1038/s41575-019-0189-8] [pmid: 31455888]
10. Zhang X, Hu P, Ding SY, Sun T, Liu L, Han S, et al. Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram. Am J Cancer Res. 2019;9(6):1266. [pmid: 31285958]
11. Arbabi M, Hasanpoor H, Arabzadeh S, Maghami P. The Synergic effect of Abujahl watermelon extract (Citrullus colocynthis) and Phycocyanin on apoptosis inducton in human colon cancer cell line (HT-29). Cellular and Molecular Research (Iranian Journal of Biology). 2020;33(2):126-135. [Link]
12. De Rivera CG, Miranda-Zamora R, Diaz-Zagoya J, Juárez-Oropeza M. Preventive effect of Spirulina maxima on the fatty liver induced by a fructose-rich diet in the rat, a preliminary report.Life Sciences. 1993;53(1):57-61. [doi:10.1016/0024-3205(93)90611-6]
13. Wu XJ, Yang H, Chen YT, Li PP. Biosynthesis of fluorescent β subunits of c-phycocyanin from spirulina subsalsa in escherichia coli, and their antioxidant properties. Molecules. 2018;23(6):1369. [doi:10.3390/molecules23061369]
14. Fernández-Rojas B, Hernández-Juárez J, Pedraza-Chaverri J. Nutraceutical properties of phycocyanin. Journal of Functional Foods. 2014;11:375-92. [doi:10.1016/j.jff.2014.10.011]
15. Chaiklahan R, Chirasuwan N, Bunnag B. Stability of phycocyanin extracted from Spirulina sp.: Influence of temperature, pH and preservatives. Process Biochemistry. 2012;47(4):659-64. [doi:10.1016/j.procbio.2012.01.010]
16. Strasky Z, Zemankova L, Nemeckova I, Rathouska J, Wong RJ, Muchova L, et al. Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis. Food & Function. 2013;4(11):1586-94. [doi:10.1039/c3fo60230c]
17. Zhang DL, Wu JH, Xie LM, Liu SQ. Molecular mechanism of C-phycocyanin in alleviation of acute lung injury in septic rats. Basic & Clinical Medicine. 2014;34(7):891. [Link]
18. Liu Y, Jovcevski B, Pukala TL. C-Phycocyanin from spirulina inhibits α-synuclein and amyloid-β fibril formation but not amorphous aggregation. Journal of Natural Products. 2019;82(1):66-73. [Link]
19. Kehrer JP. Free radicals as mediators of tissue injury and disease. Critical Reviews in Toxicology. 1993;23(1):21-48. [doi:10.3109/10408449309104073]
20. Romay C, Gonzalez R, Ledon N, Remirez D, Rimbau V. C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Current Protein and Peptide Science. 2003;4(3):207-16. [doi:10.2174/1389203033487216]
21. Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2015;1855(1):104-21. [doi:10.1016/j.bbcan.2014.09.008]
22. Alizadeh S, Esmaeili A, Omidi Y. Anti-cancer properties of Escherichia coli Nissle 1917 against HT-29 colon cancer cells through regulation of Bax/Bcl-xL and AKT/PTEN signaling pathways. Iranian Journal of Basic Medical Sciences. 2020;23(7):886-93. [doi: 10.22038/ijbms.2020.43016.10115] [pmid: 32774810]
23. Pandurangan AK. Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pacific Journal of Cancer Prevention. 2013;14(4):2201-05. [doi:10.7314/APJCP.2013.14.4.2201]
24. Patel A, Mishra S, Pawar R, Ghosh P. Purification and characterization of C-Phycocyanin from cyanobacterial species of marine and freshwater habitat. Protein Expression and Purification. 2005;40(2):248-55. [doi:10.1016/j.pep.2004.10.028]
25. Tantirapan P, Suwanwong Y. Anti-proliferative effects of C-phycocyanin on a human leukemic cell line and induction of apoptosis via the PI3K/AKT pathway. Journal of Chemical and Pharmaceutical Research. 2014;6(5):1295-301. [Link]
26. Wang J, Jiang YF. Natural compounds as anticancer agents: Experimental evidence. World J Exp Med. 2012;2(3):45. [doi:10.5493/wjem.v2.i3.45] [pmid: 24520533]
27. Jiang L, Wang Y, Yin Q, Liu G, Liu H, Huang Y, et al. Phycocyanin: a potential drug for cancer treatment. J Cancer. 2017;8(17):3416. [doi:10.7150/jca.21058] [pmid: 29151925]
28. Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12:985363. [doi:10.3389/fonc.2022.985363]
29. Gao F, Huang W, Zhang Y, Tang S, Zheng L, Ma F, et al. Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer. Oncotarget. 2015;6(36):38667. [doi:10.18632/oncotarget.5484] [pmid: 26452029]
30. Ismail NI, Othman I, Abas F, H. Lajis N, Naidu R. Mechanism of apoptosis induced by curcumin in colorectal cancer. Int J Mol Sci. 2019;20(10):2454. [doi:10.3390/ijms20102454]
31. Cheng H, Jiang X, Zhang Q, Ma J, Cheng R, Yong H, et al. Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway. Experimental and Therapeutic Medicine. 2020;19(6):3798-804. [doi:10.3892/etm.2020.8649]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Iranian Journal of Toxicology

Designed & Developed by : Yektaweb